Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: TNBC - Triple-Negative Breast Cancer|Triple Negative Breast Cancer|NSCLC|NSCLC Stage IV|Non Small Cell Lung Cancer|Non Small Cell Lung Cancer Metastatic|NSCLC Stage IV Without EGFR/ALK Mutation
Interventions: RADIATION: Sterotactic Body Radiotherapy/SBRT|DRUG: Standard of care
Sponsor: Memorial Sloan Kettering Cancer Center